Document is current
Any future updates will be listed below
-
Authors
Maeda, Yoshiko https://orcid.org/0009-0006-6115-2755
Abe, Akihito https://orcid.org/0009-0005-8799-5438
Seki, Seigo https://orcid.org/0009-0001-1501-9981
Narii, Nobuhiro https://orcid.org/0000-0002-0826-1358
Katsura, Yasuhiro https://orcid.org/0009-0000-7738-1970
Muramatsu, Yukiko https://orcid.org/0009-0006-2394-3556
Sakaguchi, Motonobu https://orcid.org/0000-0003-2310-6812
-
Funding
Funding for this research was provided by:
Takeda Pharmaceutical Company
- License Information
-
More Information
Article History
Accepted: 5 August 2024
First Online: 21 August 2024
Declarations
:
: Funding of this survey was provided by Takeda Pharmaceutical Company Limited. The open access fee was provided by Takeda Pharmaceutical Company Limited.
: All authors are full-time employees of Takeda Pharmaceutical Company Limited.
: The data that supports the findings of this study are available from the corresponding author upon reasonable request.
: All procedures in this survey complied with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The survey was reviewed and approved by the Ethics Committee of Kitamachi Clinic (May 17, 2023, TKD09522).
: Persons participating in the study were informed of the targets of the investigation, the intended use of data, and recipients of these data.
: Not applicable.
: Not applicable.
: All authors contributed, critically reviewed drafts of the manuscript and approved the final version.
